New Alzheimer's drug J4 enters first human safety tests
Knowledge-focused
Recruiting now
This early-stage trial tests whether a new oral drug called J4 is safe for people. It involves 76 healthy adults aged 18 to 64. Researchers will give single and multiple doses to see how the body handles the drug and if any side effects occur. This study does not treat Alzheimer'…
Phase: PHASE1 • Sponsor: Academia Sinica, Taiwan • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:01 UTC